TCGA studies indicate that PRKACA, a gene that encodes PKA's catalytic subunit, is amplified in 15% of ovarian tumors, in addition to the known amplification of EMSY in 11% of cases (Supplementary Figure 5). This evidence concerns the gene PRKACA and ovarian neoplasm.